So, commodity as a space, including chemical commodity, we find that probably the better times going forward. From the pipeline, I think the expensive inventory is also out and as a result of which some of these companies are looking relatively better placed on the margin front for FY25.
Divi’s Laboratories shares gain another 5% after Q2 results. Here’s why Jefferies raised target price by 23%
Shares of Divi’s Laboratories jumped 5% following a 64% YoY surge in Q2 FY27 net profit to Rs 1,127 crore. Brokerage Jefferies raised its target